Clinical trial
A Clinical Trial of Cutaneous Xylocaine Spray to Reduce Intravenous Cannulation…
NCT02562144 · Isala, Other · Completed
Key facts
| NCT number | NCT02562144 |
|---|---|
| Title | A Clinical Trial of Cutaneous Xylocaine Spray to Reduce Intravenous Cannulation Pain in Adults |
| Official title | A Randomized Clinical Trial of Cutaneous Xylocaine Spray to Reduce Intravenous Cannulation Pain in Adults |
| Acronym | Xylocaine |
| Lead sponsor | Isala, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | Xylocaine spray, Placebo |
| Enrollment | 17 |
| Start date | Apr 5, 2016 |
| Primary completion | Apr 6, 2016 |
| Completion | Apr 7, 2016 |
| First posted | Sep 29, 2015 |
| Last update posted | May 30, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: